Position in EXEL
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$10,882
+$2,304 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#665
of 754 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trust Co holds $685,358 across 17 Biotechnology names. EXEL ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARDX |
Ardelyx, Inc.
|
116,369 | $593,481 | |
| 2 | IMCR |
Immunocore Holdings plc
|
1,100 | $34,925 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
250 | $19,822 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38 | $18,875 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
200 | $10,882 | |
| 6 | MRNA |
Moderna, Inc.
|
20 | $1,400 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
7 | $858 | |
| 8 | CYTK |
Cytokinetics Inc
|
10 | $851 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,882 | 200 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $8,578 | 200 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||